Pages that link to "Q28469283"
Jump to navigation
Jump to search
The following pages link to V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies (Q28469283):
Displaying 50 items.
- Novel approaches to inhibit HIV entry (Q27013957) (← links)
- Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure (Q27312441) (← links)
- Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry (Q28475912) (← links)
- High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virus (Q28482091) (← links)
- Reliable genotypic tropism tests for the major HIV-1 subtypes (Q30372085) (← links)
- Use of mutual information arrays to predict coevolving sites in the full length HIV gp120 protein for subtypes B and C (Q30401569) (← links)
- Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography (Q30603475) (← links)
- A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity. (Q30654651) (← links)
- Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics (Q33429049) (← links)
- Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection (Q33558676) (← links)
- A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer. (Q33725702) (← links)
- HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry (Q33807529) (← links)
- HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells (Q33990552) (← links)
- Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist (Q34055508) (← links)
- Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution (Q34299053) (← links)
- A single amino acid substitution in the C4 region in gp120 confers enhanced neutralization of HIV-1 by modulating CD4 binding sites and V3 loop (Q34463861) (← links)
- CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells (Q34574397) (← links)
- A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors (Q34606129) (← links)
- Adaptive mutations in a human immunodeficiency virus type 1 envelope protein with a truncated V3 loop restore function by improving interactions with CD4. (Q34610959) (← links)
- HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage (Q34611466) (← links)
- Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing (Q34742873) (← links)
- Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies (Q35102328) (← links)
- Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques (Q35636394) (← links)
- Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity (Q35745453) (← links)
- Design and characterization of a peptide mimotope of the HIV-1 gp120 bridging sheet (Q36057328) (← links)
- Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists (Q36098903) (← links)
- Effects of partial deletions within the human immunodeficiency virus type 1 V3 loop on coreceptor tropism and sensitivity to entry inhibitors (Q36424584) (← links)
- HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120 (Q36559608) (← links)
- Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5. (Q36607127) (← links)
- CCR5 interaction with HIV-1 Env contributes to Env-induced depletion of CD4 T cells in vitro and in vivo. (Q36742476) (← links)
- Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques (Q36827168) (← links)
- A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations (Q36827946) (← links)
- Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response (Q36949880) (← links)
- Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma (Q37051645) (← links)
- Characterization of a human immunodeficiency virus type 1 V3 deletion mutation that confers resistance to CCR5 inhibitors and the ability to use aplaviroc-bound receptor (Q37145319) (← links)
- Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41. (Q37146880) (← links)
- Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain (Q37191794) (← links)
- Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain (Q37192171) (← links)
- How HIV changes its tropism: evolution and adaptation? (Q37230002) (← links)
- Genetic diversity of the highly variable V1 region interferes with Human Immunodeficiency Virus type 1 envelope functionality (Q37305864) (← links)
- HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity. (Q37360774) (← links)
- Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment (Q37410770) (← links)
- Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc (Q37452124) (← links)
- Template-constrained cyclic sulfopeptide HIV-1 entry inhibitors (Q37469187) (← links)
- Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission (Q37619606) (← links)
- Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes (Q37638959) (← links)
- Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors (Q38076139) (← links)
- A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5 (Q38341741) (← links)
- Primary infection by a human immunodeficiency virus with atypical coreceptor tropism (Q38631923) (← links)
- HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop (Q39021906) (← links)